CNBC's Jim Cramer reports on the latest news regarding Moderna.

We recently compiled a list of the Jim Cramer's Best Performers List: Top 10 Stocks. In this article, we are going to take a look at where Vistra Corp. (NYSE:VST) stands against the other stocks ...

We recently compiled a list of the Jim Cramer’s Best Performers List: Top 10 Stocks. In this article, we are going to take a look at where Carvana Co. (NYSE:CVNA) stands against the other ...

CNBC's Jim Cramer highlighted the biggest events next week on Wall Street, pinpointing earnings reports from Nvidia, TJX and Walmart. He also told investors to proceed with caution as the market ...

We recently compiled a list of the 10 Stocks on Jim Cramer's Radar. In this article, we are going to take a look at where Alibaba Group Holding Limited (NYSE:BABA) stands against the other stocks ...

CNBC's Jim Cramer on Thursday named sectors that have seen major gains recently and warned investors not to buy them while they're hot. "We have a lot of overly loved stocks in this market right ...

CNBC's Jim Cramer on Wednesday reviewed ten stocks worth more than $1 billion that have run up big this year and suggested they were smart investments — although most were also very speculative.

We recently compiled a list of the Jim Cramer’s Latest Game Plan: 15 Stocks to Watch. In this article, we are going to take a look at where DraftKings Inc. (NASDAQ:DKNG) stands against the other ...

As the night kept looking better for former President Donald J. Trump, Jon Stewart tried to “find some positivity and some good news” to report. “We are obviously digging through the results ...

CNBC's Jim Cramer on Election Day identified stocks that could perform well with either Vice President Kamala Harris or former President Donald Trump in the White House. Cramer's stock picks ...

Television personality Jim Cramer may have indirectly signaled a victory for former United States President Donald Trump in the 2024 presidential election. On Monday, Nov. 4, Cramer reviewed the ...

CNBC's Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that's been weighed down by ongoing litigation for several months. Abbott was cleared Thursday night of ...